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Although  the  blood-clotting  system presents  increasing  complexities,  it  is 
still to be hoped that there is a simple basic mechanism' at its core. If this basic 
mechanism were first apprehended,  one could then begin to superimpose the 
complexities. 
The facts at hand  are  consistent  with  the  following  concept of the  basic 
mechanism: 
Kinase 
1. Prokinase  ->  Kinase 
Kinase 
2. Prothrombin  > Thrombin 
Thrombin 
3. Fibrinogen  ÷  Fibrin 
in which all three precursors are substances closely associated with the plasma 
globulins, and all three reactions are enzymatic. 
Kinase has been concentrated from a  globulin  derivative of plasma; and it 
has been shown to activate prothrombin, even in the presence of excess oxalabe. 
Moreover, such kinase preparations, used at high dilution, have been shown to 
accelerate the activation of crude prokinase. This is in accord with  the view 
that kinase activates prokinase. 
An additional derivative of plasma globulin has been found to have an ac- 
cessory thromboplastic effect similar to  that  of platelets,  or of brain  "ceph- 
alin." These accessory thromboplastins do accelerate production of thrombin 
in crude systems. But they differ from kinase in that they are  not direct ac- 
tivators of purified prothrombin. They appear to be complicating factors super- 
imposed on the basic mechanism.  Further  particulars  are  now  given by  the 
accompanying  experiments. 
"Kinase" has often been used as a  short form of thrombokinase. Morawitz 
likened the action of thrombokinase on prothrombin to that of enterokinase 
* This work was aided by grants from the James Hudson Brown Memorial Fund 
of the Yale University School of Medicine  and by a contract from the Office of the 
Surgeon  General, Department of the Army. The figures,  except Fig. 4 b, were pre- 
sented and discussed  at a conference  on coagulation, held by the National Research 
Council , November 7,  1950. 
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on  trypsinogen,  and  apparently  considered it  a  direct  activator  (1).  These 
working concepts are herein preserved. Howell stated that thromboplastin was 
contained in platelets and in brain "cephalin" fractions; and he did not con- 
sider his thromboplastin to be a direct activator (2, 3). To that extent, Howell's 
usage is preserved for the present accessory thromboplastins. 
As  a  prologue to  further purification,  a  method  has  been  developed for 
separating clotting factors from large quantities of blood. The present account 
describes in detail a  procedure previously outlined in brief (4). 
The Fractionation Procedure 
A flow-sheet is presented in Fig. i  and the technical details are given in the 
section on materials and methods. The starting material is frozen euglobulin 
from  slaughter-house  plasma.  The  use  of  this  material  entails  certain  dis- 
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FIG.  1.  Flow-sheet  for fractionation procedure. 
advantages  which,  for  the  present,  are  outweighed by  the  conveniences it 
offers in dealing with large quantities.  Frozen euglobulin, representing more 
than 1,000 liters of plasma, has been used in developing this procedure. Globu- 
lin from more than 500 liters of plasma has been subjected to the consecutive 
adsorptions  shown  in  Fig.  1. 
When the frozen globulin is extracted with oxalated saline at pH 7.4 a large 
residue, apparently fibrin,  remains undissolved.  If left at room temperature 
a  few hours,  this  residue becomes semifluid, and capable of liquefying fresh 
fibrin. A  certain amount of fibrinolytic enzyme, or its precursor, is probably 
eliminated  with  the  fibrin at  this  point. 
The saline extract is then subjected to two successive adsorptions, the first 
by hyflo, the second by barium sulfate. The bulk of protein, including much 
fibrinogen, remains unadsorbed and is discarded. The adsorbent in each case, 
is collected by filtration, washed, and treated  with eluent without disturbing J.  H. MILSTONE  69 
the  filter-cake,  thereby  saving  much  time  and  motion.  Potentially,  these 
operations could be performed on much larger batches, and possibly could be 
adapted for use directly on oxalated plasma. They were evolved through un- 
successful attempts  to achieve a  true  chromatographic  fractionation  on ad- 
sorption columns. The yields obtained by flowing elution have been as good 
as those obtained by stirring the resuspended adsorbent with the eluent.  As 
indicated  on  the  flow-sheet,  two  fractional  elutions  are  performed  on  the 
barium sulfate. 
TABLE I 
Kjeldahl-N#rogen in the Fractions Derlved  fiom 10 Liters of Plasma 
Fraction  Volume  Nitrogen  Total nitrogen 
Saline extract.. 
Fraction A .....  ";illlili[iiii[ii[[ii[il 
Prothrombin .......................... 
Kinase and thrombin ................... 
ml. 
1970 
1000 
900 
905 
rag#rat. 
2.81 
0.203 
0.071 
0.024 
rag. 
5,540 
203 
64 
22 
TABLE II 
Activation of Prot~ombin by Fraction A 
Fro-  t  I  Period of activation 
Buffer  thrombin  Fraction A  CaCh  __  __ 
__  __  1  rain__  2 rain.  4  min____~.  8  rain.  12 min.  __ 
,n~.  ~,,~.  raZ.  ,,~.  $,c.  $ec.  l  we,.l$,~.t$ec. 
0.6  o.3  0.1  L  0.1  i  720  f  315  I  I  3s[  27 
16 mira 
$$G, 
26 
Prothrombin preparation  I was used for this  test.  The figures given in seconds report 
the time required for a 0.1 ml. sample to produce a clot, after being mixed with 0.3 ml. oxa- 
lated fibrinogen. For results without fraction A, see Table IV. 
The distribution of Kjeldahl-nitrogen in the  major fractions of a  represen- 
tative run is shown in Table I. Of the  total Kjeldahl-nitrogen  in the saline 
extract, about 5 per cent appears in the three major eluates,  taken all together. 
Fraction A 
As is evident  from Table I, fraction A  was one-tenth  the  volume of the 
parent plasma. When used at 1/11 dilution in a  prothrombin-calcium mixture 
fresh fraction A  caused fairly rapid activation,  as illustrated  in Table II. 
When fraction A was diluted to the point where its over-all thrombokinase 
activity was slight, it still showed a complementary thromboplastic effect when 
used together with crystallized trypsin, or with various globulin preparations 
derived  from plasma. This property of fraction A  fits into  an experimental 7O  lrRACTIONATION O:F BLOOD-CLOTTING  SYSTEM 
pattern  which  is  now becoming quite  familiar.  Recurrent  demonstrations  of 
this pattern,  as observed in this laboratory,  are summarized  in Table  III. 
It was first found that washed platelets, plus a globulin preparation from slaughter- 
house plasma, would together produce thrombin from prothrombin, although neither 
was effective alone (5). The effect was clearly a complementary one, and could not be 
explained as the simple addition of two qualitatively similar actions. 
Meanwhile,  it  was  found that  a  minute  quantity  of  crystallized  trypsin  could 
replace the crude globulin in this system (6).  Larger quantities of trypsin activated 
prothrombin without the help of platelets.  Indeed, trypsin could activate those pro- 
thrombins which had been purified  to the extent  that  they were no longer readily 
activated by platelets plus calcium, or by brain lipid plus calcium. These results go 
far to substantiate the view of Eagle and Harris that trypsin activates prothrombin 
(7).  There is now, however, this difference  of interpretation:  calcium plus platelets 
are not the equivalent of trypsin, but rather,  they complement trypsin. 
TABLE III 
Functional Groups of Thromboplasti¢ Matvrials 
Direct activators of prothrombin  Accessory thromboplastins 
Crude globulin (blood)  Platelets 
Trypsin (pancreas)  Bmin lipid* 
Thrombokinase  (blood)~:  Dilute, aged fraction A (blood) 
* Crude saline extract of brain contains a direct activator,  which is almost entirely absent 
from the lipid extract. 
:~ In an earlier paper, a concentrate of this factor was temporarily designated "converter," 
with  the preliminary  statement that it might represent  a thrombokinase  (4). 
It was next found that crude brain cephalin could substitute  for platelets  (6,  8). 
This strengthened the impression that it was the trypsin, and not the platelets or the 
brain lipid, which represented the primary activator of prothrombin. Prothrombin is 
considered to be a proenzyme. Trypsin activates some proenzymes. No lipid is known 
to do so. 
Since the time of Morawitz  (1),  there has been a  tendency to recognize two dis- 
tinct groups of thromboplastic materials; and since the time of Howell (2) there has 
been an understandable desire to simplify the problem by assuming that they are all 
basically alike.  However, Rumpf in 1913 (9) and later,  Leathes and Mellanby (10) 
emphasized that certain lipids  functioned in a  different way than  thrombokinases. 
Lenggenhager stated that his thrombokinin could be derived from plasma, but was 
not  carried  by platelets  (11). 
More  recently,  the  contributions  of  Ferguson  and  Erickson  (12),  Qaick  (13), 
Owren  (14),  Zondek  and  Finkelstein  (15)  Fantl  and  Nance  (16),  Honorato  (17), 
Ware Guest, and Seegers  (18),  Mann, Hum, and Magath (19),  Quick and Stefanini 
(20),  Alexander,  deVries,  Goldstein,  and Landwehr  (21),  and Jacox (22)  have sug- 
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sical  prothrombin,  enhance  the  rate of over-all thrombin production.  It would  be 
rash to conclude  arbitrarily that there are only two functional groups of thrombo- 
plastic materials, or only one type of thromboplastic lipid. 
It is sufficient to note  that  experimental methods  are now better able  to 
distinguish  between  the  two  classes, of  thromboplastic  materials  listed  in 
Table III and that  the factor which is conspicuous in the diluted  fraction A 
belongs to the group of accessory thromboplastins. Since the activation tests 
followed the pattern previously demonstrated (5, 6), they will not be reported 
in detail, except for the brief example in Table IV. There, it is seen that dilute 
fraction A  plus  kinase  caused  thrombin  to be produced  many times as fast 
as with fraction A  or kinase alone. Other,  corroborating, experiments showed 
that  dilute  fraction A  and  kinase  together  caused more rapid production  of 
TABLE IV 
Complementary E gent of Dilute Fraction A and Dilute Kinase 
Buffer 
ml. 
0.7 
0.6 
0.7 
0.8 
Prothrom- 
bin 
0.2 
0.2 
0.2 
0.2 
Fraction A 
1/lo 
0.1 
0.1 
None 
None 
Kina~ 
1/16o 
ml. 
None 
0.1 
0.1 
None 
CaCh 
ml. 
0.1 
0.1 
0.1 
0.1 
Period of activation 
10 min.  20 rain. 
$$$.  $$C. 
> 1800  > 1800 
6O  42 
> 1800  > 1800 
>1800  >1800 
Prothrombin preparation I was used for these tests.  Fraction A had been stored at 5°C. 
for 28 days, and  diluted just before the experiment. (The aging was not necessary.) The 
kinase was prepared from the kinase -k thrombin fraction  (cf. Fig. 1), as described under 
Methods. Figures in the body of the table give clotting times of 0.1 ml. samples mixed with 
0.3 ml. oxalated fibrinogen. 
thrombin than four times as much of either reagent without the other.  Thus, 
the  two  reagents  complemented each  other  in  a  way that  could  not be the 
simple addition  of qualitatively similar effects. 
Preparations were assayed for accessory thromboplastin on a  comparative 
basis, by testing dilutions in prothrombin conversion mixtures which needed 
accessory thromboplastin, and comparing thromboplastic effects. For example, 
dilutions of various fractions could be substituted for dilute fraction A in the 
system of Table IV. In general, about half of such activity as found in the saline 
extract,  was accounted  for in fraction A; and perhaps as much as one-fifth 
of it remained with the bulk of protein, unadsorbed by the hyflo. This factor 
was most stable when the pH of fraction A  was kept between 5.4 and  7.3; 
and there was an optimum near the middle of this range. The factor deterio- 
rated more rapidly in 0.1  ~t NaC1 than in 1.4 ~  KC1. 72  J~RACTIONATION OF BLOOD-CLOTTING SYSTEm[ 
Attempts to separate the two complementary components of fraction A were 
only partly successful, and there were large apparent losses of activity. A large 
amount of accessory thromboplastin with relatively little kinase could be pre- 
cipitated from fraction A at pH 6.4 in the presence of 0.3 saturated ammonium 
sulfate plus the fraction's original potassium chloride. From the resulting fil- 
trate,  thrombokinase could be precipitated by adding ammonium sulfate to 
0.6 saturation.  Studies of  this kinase have  not disclosed any essential dif- 
ference from the kinase to be described below; and it is not necessary, as yet, 
to consider them as two different kinases. Of the total potential kinase avail- 
able in the crude saline extract, a large part was removed with fraction A. 
It is  clear,  however,  that fraction A  contains both kinase and accessory 
thromboplastin, and that it is the accessory thromboplastin which predom- 
inates when fraction A  is diluted. 
Prothrombin 
Although a  small amount of prothrombin could be detected in fraction A, 
more than 90 per cent of it went through the hyflo step along with the bulk of 
the proteins. In this material, the prothrombin was readily activated by add- 
ing calcium and fraction A. When brain lipid (which has extremely little kin- 
ase)  was substituted for fraction A,  there was a  well marked latent period 
followed by a sharply accelerated production of thrombin. The interpretation 
offered is that prothrombokinase still accompanied the crude prothrombin at 
this stage of the procedure. Following the addition of calcium and brain lipid, 
the prokinase was activated autocatalytically, thereby furnishing the neces- 
sary kinase for the conversion of prothrombin. 
The quantity of barium sulfate used to adsorb the prothrombin was chosen 
for optimal specific activity rather than maximal yield; and from 20 to 45 per 
cent of the prothrombin was left unadsorbed. The use of larger amounts of 
barium sulfate resulted in eluates with lower specific  activities. Most of the 
adsorbed prothrombin could be eluted by 0.3 ~  phosphate, pH 6.6. Such pro- 
thrombin, although of a rather high specific activity, was still far from pure; 
and interesting differences have been noted in various subfractions. When the 
eluates were treated with filter-cel, precipitated with ammonium sulfate, and 
subjected to isoelectric fractionation, small fractions were obtained, in which 
only slight contamination with kinase or other significant impurity was recog- 
nized  (see  Methods). 
Thrombokinase and Thrombin 
Prothrombin eluates obtained with 0.3 M phosphate were not entirely stable. 
Eluates obtained with 0.1 ~ phosphate, pH 6.6, had less prothrombin, but also 
less  lability. When parallel batches were eluted by different phosphate solu- 
tions, the prothrombin eluates obtained with the more concentrated or more I.  H.  ~m.STONF,  73 
alkaline  phosphate  solutions  showed  greater  lability.  These  differences  in 
lability were large, and were still evident when the fresh eluates were promptly 
dialyzed and aged in the same medium. 
Such differences also appeared in successive eluates.  After the elution with 
0.3 M phosphate, pH 6.6, a second elution was performed with 0.6 ~  phosphate, 
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FIG.  2.  Activation of prothrombin by kinase.  All activation mixtures  contained 
0.4 ml.  of prothrombin preparation  II, except  the  "Ca, kinase"  test,  in which 0.4 
ml.  distilled  water was substituted.  Ca, kinase,  thrombin,  and  oxalate were added 
where indicated, in the amount of 0.1 ml. The volume was made up to 1.1 ml. with 
veronal-buffered saline,  and all mixtures were pH 7.3 by phenol red. The uricorrected 
thrombin  values were derived by dividing 3,000  by the test  clotting times.  Minor, 
but  very interesting,  corrections which might have  been  made,  are  not  discussed 
here because they do not affect the validity of the conclusions drawn  in  the text. 
The stock potassium oxalate was 0.1272 ~, making the activation mixture more than 
0.01 ~  with respect to oxalate. At the end of the experiment, the clear oxalated mix- 
ture was mixed with  CaCI2; and it gave a heavy precipitate.  A further experiment 
showed  that  the  activation  rate  was  no slower with  3  times  as much oxalate.  In 
both cases oxalate was added before kinase. A later experiment showed that the same 
prothrombin reagent was not activated by oxalate plus brain lipid.  The last  2  ex- 
periments  are not illustrated  in  the figure. 
pH 7.9. The protein concentrated from the second eluate  contained not pro- 
thrombin, but thrombin.  Since the evidence on this point is not yet complete, 
the following is offered only as a  tentative  explanation.  An inactive form of 
kinase,  possibly prokinase,  was adsorbed with  the  prothrombin.  During  the 
subsequent  steps,  active kinase was liberated,  and proceeded to activate  the 
prothrombin, in the absence of ionic calcium. If this explanation were correct, tSO- 
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FzGs. 3 a  and 3 b. Fig. 3 a  with k/nase 1/11  and Fig. 3 b with kinase 1/176.  The 
importance of calcium for the accessory  effect  of brain lipid. Protahrombin  prepara- 
tion II was present in all tests, which were performed like those of Fig. 2. The brain 
lipid was added as 0.I ml. of a  1/100 dilution  of a  10 per cent stock suspension. The 
dilutions of kinase are final dilutions in the activation mixtures. The X  on the ver- 
tical axis of Fig. 3 a shows the amount of thromb~n contaminant contributed by the 
prothrombin and klnase reagents at the start.  The P  on the vertical axis of Fig. 3 b 
shows the amount of thrombin contaminating  the pro~rombin. There has been much 
less of this annoyance with prothrombin preparation I  (of.  TaMe IV). 
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then the concentrated protein should contain not only thrombin, but  also 
kinase. 
It did. By repeatedly selecting those proteins soluble in 0.35 but precipitated 
by 0.45 saturated ammonium sulfate, kinase subfractions were obtained which 
showed  only slight contamination with thrombin. Proteins soluble  in 0.45, 
but precipitated by 0.6 saturated ammonium sulfate, were selected to yield the 
thrombin subfractions. 
Fig. 2 shows that the kinase could activate prothrombin with or without the 
addition of calcium chloride, and even in the presence of excess oxalate. The 
two lowermost curves reveal that both the prothrombin and the kinase reagents 
contained small amounts of thrombin, which did not increase during the test. 
The next higher line shows that a larger amount of thrombin, furnished by the 
thrombin subfraction, failed to activate prothrombin. The V-shaped symbols 
show that the same amount of thrombin subfraction had no effect on the ac- 
tivation  of prothrombin  by kinase. 
Fig. 3 a reiterates that kinase can activate prothrombin without the addi- 
tion of calcium. Without calcium, the further addition of brain lipid did not 
hasten production of thrombin. However, when kinase activated prothrombin 
in the presence of calcium, then the brain lipid was able to exert its accessory 
effect, as demonstrated by the contrast between the two uppermost curves. 
The effect of the lipid was more conspicuous in the early stages of activation 
(Fig.  3 a),  and when the kinase was  dilute  (Fig.  3 b).  Control experiments 
showed that lipid, Ca, and kinase did not produce thrombin unless prothrombin 
was included. Other controls showed that the principal effect of the lipid could 
not be attributed to a prompt hastening of the thrombin-fibrinogen  reaction, 
with spurious  increase  in thrombin values. 
Greater dependence on calcium furnishes another characteristic distinguish- 
ing the accessory thromboplastins from the primary activators of prothrombin. 
This applies  alike to the different accessory  thromboplastins listed in Table 
III. In experiments  such as those of Fig. 3 b, either platelets or dilute fraction 
A could be substituted for brain lipid. But neither platelets nor dilute fraction 
A exerted much effect unless  calcium  chloride was also included. 
As already indicated, fraction A contained a relatively large amount of ac- 
cessory thromboplastin, along with some kinase.  In the presence  of calcium, 
and in the amount used for the experiment of Table II, it caused more rapid 
production of thrombin than the amount of kinase used for the experiments 
of Figs. 2 and 3 a. However, without the addition of calcium, the same amount 
of fraction A was practically inert. To this extent, the behavior of fraction A 
was like that of the artificial mixture of dilute kinase and accessory thrombo- 
plastin, illustrated in Fig. 3 b, but even less active without calcium. 
Contrariwise,  the behavior of concentrated kinase did not suggest  such a 
mixture. If it is suspected  that the activity of concentrated kinase depends on 76  FRACTIONATION  OF  BLOOD-CLOTTING  SYSTEM 
its containing two biologic factors, it is difficult to suppose that one of them is 
accessory thromboplastin; because the latter is not effective in the presence of 
oxalate,  whereas  concentrated kinase  is. 
Previously (23), when crude kinase was obtained by conversion of crude pro- 
kinase, it activated prothrombin only very slowly, if the concentration of cal- 
cium was reduced. For this and other reasons, it is probable that such crude 
kinase contained accessory thromboplastin.  Indeed, it was indicated at that 
time that the crude prokinase might contain an activator complex with more 
than  one  significant  component. 
Comparison of Fig. 3 b with Fig. 3 a  demonstrates that smaller quantities 
of kinase could be detected if calcium and accessory thromboplastin were in- 
cluded in the system. With this more sensitive test, it was found that there was 
still  a  considerable  amount of kinase  in  the  thrombin  subfraction.  But the 
concentration of kinase, as so estimated, did not parallel thrombin.  The ratio 
of kinase to thrombin was 100 times as great in the kinase subfraction as in the 
thrombin subfraction. 
This degree of separation was achieved by rejecting a large part of the total 
activity in order to concentrate a  small sample of kinase with little contam- 
inating thrombin. Only 10 ml.  of concentrate was derived from 55 to 60 liters 
of plasma. Because of the losses by rejection and other large  losses, the con- 
centrate does not afford a full measure of the potential activity of the parent 
plasma. As far as kinase and prokinase are concerned, the present methods are 
exploratory. 
Table IV illustrates the complementary effect of dilute fraction A and dilute 
kinase.  The amount of fraction A  in  the activation mixtures represents the 
equivalent of diluting fraction A to 11 times the volume of the parent plasma. 
The dilution of kinase in the mixtures corresponds to diluting 10 ml. of concen- 
trate  to  17.6  liters.  In  other experiments the  kinase was  detectable in  the 
proportion of 10 ml. of concentrate diluted to the original 55 liters. 
These quantitative relations offer no reason for doubting  the physiologic 
significance  of  the  kinase.  However,  other  quantitative  considerations  cast 
much doubt on its purity. In some runs, there was almost as  much kinase in 
the thrombin, as in the kinase subfraction, the principal difference being that 
the kinase subfraction had only 1/100 as  much thrombin. It is quite possible 
that kinase represented only a  small  proportion of the total protein of these 
preparations.  Moreover,  1  microgram  of crystallized trypsin  would  replace 
100 micrograms or more of kinase subfraction, in the activation of prothrom- 
bin. Like kinase, trypsin could activate prothrombin in the presence of oxalate. 
The A ctlvator of Prothrombokinase 
The latent period in the activation of fresh, crude prothrombin is concerned 
with the activation of the prokinase which contaminates the prothrombin (23). J.  ~.  ~ILSTONE  77 
Various fractions described here  contained a  factor which could shorten  the 
latent  period.  According to this presumptive two-stage test,  the kinase sub- 
fraction was  100 times  more concentrated in this factor, than was fraction A. 
This tended to associate the activator of prokinase with kinase,  rather than 
with accessory thromboplastin. 
With  the more explicit  three-stage analysis,  it was found that  the kinase 
subfraction, at high dilution, accelerated the activation of crude prokinase, as 
shown in Fig. 4 a. However, the thrombin subfraction was almost as capable 
in this respect, as shown in Fig. 4 b. These two subfractions had shown simi- 
lar concentration of kinase,  but  a  100-fold  difference in  thrombin.  In these 
two preparations,  as well as in others,  the capacity to accelerate the activa- 
tion of prokinase was proportional to the concentration of kinase, not to the 
concentration of thrombin. 
In the  three-stage  analysis,  seed material  diluted  45,056-fold in  the  prokinase 
mixture was later diluted  10-fold more in the prothrombinmixtures,  (compare  1/450,- 
560 with the dilution of 1/160  X 1/11 = 1/1,760 in Table IV), and finally 4-fold more 
in the fibrinogen mixtures.  Under these conditions, the present  seed materials  could 
offer no interference  in the second and third stages.  The observed  effect  depended 
entirely  on their acceleration  of prokinase  conversion. The amount of kinase added 
as seed was very small compared to  that  developed  from  the  prokinase.  This  was 
further verified by a seeded three-stage  test which followed the kinase activity dur- 
ing the first 2 minutes, before the rapid rise. 
Materials and Methods 
Hyflo.--Hyflo  super-eel, a  grade  of diatomaceous  silica supplied  by Johns-Man- 
ville  Corporation,  New  York,  New  York. 
Filter-Cel.--Another  grade  of  diatomaceous  silica. 
E & D Filter Paper.--The Eaton-Dikeman Co., Mt. Holly Springs, Pennsylvania. 
BaSO4.--v.s.P.,  "suitable  for x-ray diagnosis,"  supplied by Merck and Co., Rah- 
way, New Jersey.  Some stocks  of  analytical  reagent  are  not  satisfactory  for the 
present procedure. BaSO4 was used for absorption  of "serozyme" by Bordet and De- 
lange (24), and of prothrombin by Dale and Walpole (25), and recently by others (21, 
26, 27). 
Oxalated Salt Sobution.--NaCl  36 gm. 
K~C~O4 +  H~O  20 gm. 
Distilled water to 2 liters 
4 "~  NaCl.--  NaC1  1404 gin. 
Distilled water to 6 liters 
1.4 ~  KCI, pH 6.7.--  KCI  626 tim. 
0.1 ~ KH~PO~  300 ml. 
0.1 N NaOH  210 ml. 
Distilled water to 6 liters 
The pH values for this and the following solutions were read with a glass electrode. I00'  SI:EDED  WITH  KINASE  IJ45,056 
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Fxos. 4 a  and 4 b.  Fig.  4 a  with  unseeded  control and Fig.  4 3 with  comparison 
of kinase  and  thrombin.  Three-stage  analysis  showing that  the kinase  subfraction 
accelerated activation of prokinase more than did the "thrombin" subfraction. The 
kinase subfraction had a little more kinase, about 1/3 as much protein, and 1/100 as 
much thrombin, as compared with the "thrombin" subfraction. The dilutions given 
are final dilutions in tlle prokinase activation mixtures. The undiluted kinase had 0.35 
rag.  protein  N  per  mL  by  turbidity,  and  caused  acceleration  in  dilutions  beyond 
1/45,056. 0.02 ug. protein N  per ml. represents a  conservatively high estimate of the 
amount  required  to  cause  detectable  acceleration.  For  each  test,  0.1  ml.  of  seed 
material  (or buffer control) was added to 0.9 ml. crude prokinase, and 0.1 ml.  CaC12 
was  added 15 seconds later. At 4 minute intervals, timed from the addition of CaCI~, 
samples  were assayed  for kinase  activity  by determining  how much  prothrombin 
they would activate in 2 minutes. 
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The readings did not vary more than 0.1 unit from the values given. 
Wash, pH 6.7.--  4 M NaC1  125 ml. 
0.1 M KH2PO,  250 ml. 
0.1 •  NaOH  120 ml. 
Distilled water to 5 liters 
0.3 at phosphate, pH 6.6.--KH~PO,  81 gm. 
1 N NaOH  275 ml. 
Distilled water to 2 liters 
Phosphate solutions were used by Munro and Munro  (28)  to elute prothrombin 
from AI(OH)s, and by Fanfl and Nance (29)  to elute prothrombin from BaSO,. 
0.6 at phosphate, pH 7.9.--KH2P0,  163 gm. 
1 ~ Na0H  1110 ml. 
Distilled water to 2 liters 
0.005 M acetate, pH 5.3.-- 4 ~  CH3 COONa  4.0 ml. 
4 ~  CH3 COOH  1.0 ml. 
Distilled water to 4 liters 
SAS.--Saturated ammonium sulfate. 
0.1 SAS: 0.1 ~¢ acetate, pH 5.25.--  SAS  100 ml. 
4 ~r CH3COONa  21 ml. 
4 ~r CI-I3COOH  4 ml. 
Distilled water to 1 liter 
0.35 SAS: 0.I at acetate, pH 5.25.--SAS  350 ml 
4 ~r CH3COONa  21 ml. 
4 ~r CH3C00H  4 ml. 
Distilled water to 1 liter 
0.45 SAS: 0.1 at acetate, pH 5.25.--SAS  450 ml. 
4 ~  CI-I~COONa  21 ml. 
4 ~r CI-I~COOH  4 ml. 
Distilled water to 1 liter 
Veronal-Buffered Saline.--0.9 per cent NaCI: 0.02  ~  veronal, pH 7.4 (5). 
Platelets.--Twice  washed  rabbit  platelets  (5). 
Lipoid Thromboplastin.--That  fraction of bovine brain, soluble in ether, but not in 
acetone (6). 
Crystallized Trypsin.--Stock solution prepared as described (6). 
Prothrombin Preparation/.--by Mg (OI-I)2, as described (23). 
Prothrombin  Preparation  //.--by  BaSO4,  as  described  below. 
Preparation  of Major Fractions.--Frozen  euglobulin was  obtained from  Armour 
and Co., of Chicago, through the cooperation of Dr. J. B. Lesh. Citrated bovine plasma 
was diluted with 10 volumes of cold tap water and the pH brought to 5.1 by addition 
of 1 per cent acetic acid. Mter settling overnight in the cold, the supernatant was dis- 
carded and the precipitate was shipped by air express, packed in dry ice. At the lab- 
oratory, this material was stored at -17°C. The weight of the frozen precipitate from 
100 liters of plasma was usually between 4 and 6 kg. To avoid continuous changes 
in procedure,  540  gin.  was  arbitrarily taken  as roughly equivalent to  10  liters of 
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540 gm. of precipitate was broken up with a  cold chisel,  passed through a  meat 
grinder, and mixed with 900 ml. distilled water plus 1 liter of cold oxalated salt s01u- 
tion. This mixture was stirred electrically with a glass rod bent at the bottom into a 
wide triangle, thereby moving the entire suspension without causing much foaming. 
During the stirring, about 170 ml. 0.1 ~  NaOI-I was added dropwise until a phenol 
red spot test matched that of a pH 7.4 buffer. The mixture was centrifuged and the 
residue set aside. To the supernatant was added 400 gm. hyflo, which was kept sus- 
pended by occasional stirring for 20 minutes. A suspension of 100 gin. hyflo in 500 ml. 
wash was used to precoat an E  & D No. 615 filter paper on a Buchner funnel 24 cm. 
in diameter. Finer filter paper was not satisfactory, leading to excessive  slowing of 
filtration. 
The filters were handled as if they were flat chromatographic columns.  I Fluids were 
poured on in batches; and these were kept reasonably separate by waiting until only 
a thin layer of preceding fluid remained over the filter-cake, before the next was poured 
on. 
The hyflo-globulin mixture was poured on the prepared filter and filtration with 
suction was performed slowly until the amber globulin just began to emerge.  At this 
point filtration was stopped, and about 470 ml. filtrate was discarded. Filtration was 
then completed within 10 minutes. Now, 500 ml. wash was drawn into the filter-cake, 
which was then packed by pressing with a spatula. Next 1,000 ml. wash was drawn 
into the cake; and about 2450 ml. of amber filtrate was removed from the flask, and 
stirred with 800 ml. cold 4 ~ NaC1. The salted globulin could be processed  at once or 
stored overnight at 4°C. Another 1,000 ml. of wash was drawn into the cake; the fil- 
trate was discarded and the flask rinsed with distilled water. 800 ml. 1.4 •  KC1 was 
poured on the filter; and the suction was adjusted so that 20 minutes were required 
to draw the KC1 into the cake. The filtrate was discarded. Another 800 ml.  1.4 
KC1 was poured on the filter and filtration was completed slowly. The 800 to  1,000 
ml. of opalescent filtrate was fraction A. About 140 minutes were required for the 
adsorption, filtration, washing, and elution. As routine, two batches were run, from 
the frozen globulin to fraction A  in 5 hours. 
Initially, difficulty was met in performing two successive adsorptions with globulin 
solutions which contained so much fibrinogen. Apparently this was largely due to the 
tendency of the fibrinogen to clot during the process.  This diCficulty was avoided by 
salting the globulin after the first adsorption and by selecting the proper stock of 
BaSO4, for different stocks varied in their suitability for this procedure. If the salted 
globulin had been stored at 4°C., it was warmed for 15 minutes in a water bath at 
26-30°C. Meanwhile a suspension of  10 gin. hyflo in 300 ml. 1.4 M KCI was used to 
precoat a No. 612 E  & D  filter paper on a Buchner funnel 24 cm. in diameter. 150 
gm. BaSO4 was added to the globulin and stirred continuously  for 10 minutes. Then 
60 gm. hyflo was added and stirred well for 2 to 3 minutes. Filtration was begun at 
moderate speed,  the mixture being poured with care not to disturb much of the pre- 
coat. After the first few seconds, the suction was turned on full; and filtration was 
completed in 15 to 30 minutes. The BaSO4-globulin suspension was followed by 500 
1 The writer is indebted to Dr. Harold G.  Cassidy of Yale University, for an in- 
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ml.  1.4  ~  KC1  and  the  filter-flask was  emptied.  Then  1500 ml. wash  was passed 
through; and the flask was emptied and rinsed with distilled water. The first elution 
was performed by drawing 900 ml. 0.3 M phosphate, pH 6.6, through the cake in 30 
to 40 minutes. The second eluate was obtained in a similar manner with 900 ml. 0.6 
M phosphate, pH 7.9. Sometimes twice as much hyflo was needed for rapid filtration. 
Sometimes the procedure was  interrupted just before  the  first elution, and  the 
washed  BaSO4 was  stored at  -17°C.  Often, the BaSO, was  stored  in the  freezer 
after the first elution; and the second eluates were prepared from the stored cakes, 
as needed. 
As an extension of this major fractionation procedure, the following exploratory 
fractionations have been done. 
Kinase and Thrombin Subfractions.--The  second eluates from 6 BaSO4 cakes  were 
pooled. For each liter, 474 gm. solid ammonium sulfate was added, and stirred well. 
The precipitate was collected on a Buchner filter with 33 gm. hyflo as filter-aid. The 
moist, undisturbed filter-cake was kept in the refrigerator 23 hours and then at room 
temperature for ½  hour. For the next ½  hour, 600 ml. wash was drawn slowly through 
the cake, which was finally pressed with a spatula. To 650 ml. of amber filtrate, there 
was added 351 ml. SAS. After 2 hours, the precipitate was removed by centrifugation. 
To 980 ml. of supernatant was added 435 ml. SAS. The precipitate was collected by 
centrifugation, dissolved in 40 ml. wash, kept at 5°C. for 1 week, and mixed with 33 
ml. SAS, to give a kinase precipitate and a thrombin supernatant. All fractionation 
was done at room temperature, but the fractions were  stored at 5°C.  at the end of 
each day. 
The kinase precipitate was extracted with 20 ml. 0.35 SAS : 0.1 M acetate, and the 
residue discarded. The extract was mixed with 3.9 ml. SAS; and the resulting pre- 
cipitate was extracted with 15 ml. 0.35 SAS : 0.1 ~r acetate. The extract was recen- 
trifuged the next day to remove a precipitate which had formed overnight in the cold; 
and the extract was then mixed with 2.7 ml. SAS. The resulting precipitate was ex- 
tracted with 5 ml. 0.35 SAS : 0.1 ~  acetate; and the extract was mixed with 0.9 ml. 
SAS. The resulting precipitate was dissolved in 15 ml. wash, and reprecipitated with 
12.3 ml. SAS. The precipitate was dissolved in 20 ml. wash and reprecipitated with 
16.4 ml. SAS. This last pair of operations, (20 ml. wash, then 16.4 ml. SAS) was re- 
peated to make a total of 12 such precipitations. The final precipitate was dissolved 
in 10 ml. wash and dialyzed against several changes of cold veronal-buffered saline, 
over a period of 4 days. 
76 ml. of the thrombin supernatant was mixed with 28.5 ml. SAS. The resulting 
precipitate was extracted with 20 ml. 0.45  SAS : 0.1 ~  acetate. 22 ml. extract plus 
8.3  ml.  SAS gave a  precipitate which was extracted with  10 ml. 0.45  SAS : 0.1 
acetate. This extract plus 3.8 ml. SAS gave a precipitate, which was extracted with 5 
ml. 0.45 SAS : 0.1 M acetate. Mter removal of a precipitate which formed overnight 
in the cold, the extract was diluted with 5 ml. wash, and dialyzed in the same beaker 
with the kinase subfraction. 
The principle involved in this separation has been used repeatedly, with many 
variations in detail. 
Prothrombin Preparation  //.--900  ml.  fresh  prothrombin eluate  was  stirred  10 
minutes with 13.5 gm. filter-cel, and filtered through No. 612 E  & D paper on a Buch- 82  FRACTIOI~ATION" O1  e  BLOOD-CLOTTING SYSTEM 
ner funnel 9 cm. in diameter. Two such batches were combined and stirred with 352 
gm. ammonium sulfate per liter of filtrate. After ½  to 1 hour, 10 gm. hyflo was stirred 
in, and the suspension filtered on a 9 cm. E  & D  No. 612 paper, precoated with 1 gm. 
hyflo (suspended in 0.65  SAS). The filter-cake was washed with 100 ml. of 0.45 SAS : 
0.1  ~  acetate. Then  2  successive 100 ml. portions of 0.1  SAS : 0.1  M acetate were 
slowly drawn through the filter over a period of 30 to 45 minutes, to yield about 200 
ml. of prothrombin  solution. This was dialyzed in  the cold against several changes 
of 0.005  M acetate, pH 5.3, and the resulting precipitate removed by centrifugation 
in the cold. To the supernatant, cold 0.1 N HCI was cautiously added until a spot test 
with brom cresol green matched that of a pH 4.4 buffer. The precipitate was removed 
by centrifugation in the cold. After the supernatant had been at 5°C.  for a  day or 
two more precipitate formed; and this was removed. The supernatant contained pro- 
thrombin, with only traces of kinase. 
Several variations of this method have been used, all of them having in common 
the selection of prothrombin remaining in solution after isoelectric precipitation at 
pH 4.4 to 4.8. At this point most of the prothrombin is lost in the precipitate, along 
with kinase or its precursor. However, the supernatant is almost as low in kinase as is 
prothrombin preparation I; and it differs from preparation I  in an interesting way, 
which will be described elsewhere  (8). 
Three-Stage Analysis  and  Other Coagulation Tests.--As  described  (23). 
Protein-N.--Turbidity  method  of Northrop  (30),  standardized by Kjeldahl (31) 
on crude globulin. 
Kjeldahl-N.--Microanalysis,  using digestion and  distillation procedure  of Hiller, 
Plazin, and  Van  Slyke (32).  The  distillate was collected and  titrated according to 
Kunitz (31). 
DISCUSSION 
The  understanding  of  the  clotting system  will  depend  ultimately on  the 
isolation of its components. To do this, it is desirable to know what are  the 
components to be isolated, and to have some idea of what they do  and  how 
they can be  measured.  Thus,  even a  purification program  needs  a  working 
hypothesis. At the present stage of purification, it is profitable to check  the 
new facts against the basic hypothesis: 
Kinase 
1. Prokinase  ~  Kinase 
Kinase 
2. Prothrombin  ~  Thrombin 
Thrombin 
3. Fibrinogen  ~  Fibrin 
The crucial questions concern kinase, which is defined as a direct activator of 
prothrombin.  It is concluded that the concentrated plasma derivatives herein 
called kinase do contain kinase; for they have never failed to activate a  pro- 
thrombin preparation, no matter how purified. 
Platelets, brain lipid, and dilute fraction A are considered not to be primary j.  H.  mT.STO~  83 
activators; for they cause little or no activation of purified prothrombin, even 
in the presence of calcium. However, they do accelerate production of throm- 
bin, provided that both kinase and calcium are included with the prothrombin. 
Therefore, they are classed as accessory thromboplastins. The rate of over-ail 
thrombin production depends on the rates of prothrombin activation, of side 
reactions, and of thrombin inactivation. This leaves open several conceivable 
modes of action for these thromboplastins. 
Concentrated  kinase  activates  prothrombin  in  the  presence  of  oxalate. 
Accessory thromboplastins are effective only when calcium is added, and are 
practically inert in the presence of oxalate. Hence, they do not significantly 
contribute to the effect of kinase in the presence of oxalate, even if they hap- 
pen to contaminate the system. It is concluded that kinase can activate pro- 
thrombin, unaided either by ionic calcium or by accessory thromboplastin of 
the type studied. 
Heretofore, concentrated kinase  preparations,  as here described, have not 
been available for continuous and repeated study. When kinase is dilute and 
the test system crude, the addition of accessory thromboplastin plus calcium 
makes an enormous difference in the rate of thrombin production. Under these 
conditions, calcium and accessory thromboplastin  (e.g. platelets,  "cephalin") 
can easily be mistaken for direct activators. They often have been. It is now 
seen that ionic calcium and accessory thromboplastin are neither absolutely 
necessary, nor together sufficient, for the activation of prothrombin. 
Under proper conditions, highly purified thrombin preparations will show 
kinase activity. But the ratio of kinase to thrombin varies, and is 100 times 
as great in the present kinase fraction as in the thrombin fraction. This strongly 
favors the view that kinase and thrombin are distinct entities, and that kinase 
commonly contaminates thrombin. 
The kinase  preparations  sharply  accelerate the  conversion of  crude pro- 
kinase. Other fractions behave similarly. But the extent to which the fraction 
can be diluted and still show this effect, is roughly proportional to the amount 
of kinase,  and far out of proportion to thrombin or to accessory thrombo- 
plastin. Although more complicated interpretations must be kept in mind, the 
simplest explanation is that kinase activates prokinase.  It has  already been 
shown that the conversion of crude prokinase follows the course of an auto- 
catalytic reaction (23). 
Several years ago, it was  reported that concentrated crude prothrombin in am- 
monium  sulfate solution,  changed  to thrombin without the addition of extraneous 
activators and in the absence of ionic calcium. The essential condition for "spontane- 
ous" activation seemed to be the concentration of the biologic material, which might 
have been either the prothrombin itself, or some accompanying  factor (33). It has 
now been shown that dilute prothrombin in dilute salt solution can be activated in the 
presence  of oxalate by concentrated kinase.  Moreover, it has been possible  to find 84  FRACTIONATIOIq OF BLOOD-CLOTTING SYSTE~f 
kinase in thrombins resulting from "spontaneous" activation, and to separate some 
of the kinase from  the thrombin in a  moderately effective manner. 
During the present work, it was found extremely difficult to remove the last traces 
of kinase and its precursor from prothrombin subfractions. These traces, although of 
little consequence in dilute solution would become more effective when the protein 
was concentrated. Until there is some valid criterion for distinguishing a truly spon- 
taneous  conversion  of  prothrombin,  it  is well  to  suspect  that  those  prothrombin 
concentrates which become active "spontaneously" are contaminated with prokinase 
.or kinase. 
"Spontaneous"  activation of prothrombin was encountered by Cekada  (34)  and 
Mellanby (35),  and probably also by Parfentjev (36).  Quite recently, Seegers, Mc- 
Claughry, and Fahey reported the autocatalytic kinetics observed for the activation 
of concentrated prothrombin in sodium citrate (37).  They did not discuss the pos- 
sibility that  their prothrombin  might  be  contaminated  with  prokinase,  and  their 
thrombin with kinase. A plasma derivative that activated prothrombin in the pres- 
ence of oxalate was described by Tagnon (38) who compared his factor to the throm- 
bozyme of Nolf (39). 
Although ionic calcium is ordinarily very important for the conversion of prothrom- 
bin, there is now ample evidence that it is not indispensable. Calcium is also important 
for the activation of prokinase (23).  That calcium may not be absolutely necessary 
for this reaction either, has been suggested by incidental observations which require 
further study. 
It has usually been possible to substitute crystallized trypsin for thrombokinase. 
However, the two do not appear to be the same. Certain preparations of serum pro- 
tein have here been found to depress the activation of prothrombin by trypsin, whereas 
they exerted little influence on the activation of prothrombin by kinase (cf. Travis 
and Ferguson (40)). It is also probable that thrombokinase is distinct from that par- 
ticular fibrinolytic enzyme called plasmin  (41).  This does not mean that thrombo- 
kinase is not  an enzyme, nor does it even exclude the possibility that  the kinase, 
under proper conditions, might  show  some proteolytic or fibrinolytic activity. 
Although accessory thromboplastin was recovered in good yield from the plasma 
globulin, it is not certain to what extent this material is distinct from the functionally 
similar factor in platelets. The globulin precipitate from slaughter-house plasma may 
well have included platelet material. Further, there is some doubt that plasma, as it 
circulates during life, is ever entirely free of platelet material. On  the other hand, 
the possibility must be considered that functionally  similar material might originate 
from sources other than platelets, and also be found in the plasma globulins. Regard- 
less of  source,  it  is  advantageous  to  group  all such  functionally similar materials 
together  as  accessory thromboplastins.  This  preserves for  platelets and  for  brain 
"cephalin"  the  designation  "thromboplastin,"  applied to  them  by Howell  (2,  3). 
They are now further qualified as accessory thromboplastins in order to distinguish 
them more emphatically from the primary activator, thrombokinase. It is quite prob- 
abie that accessory thromboplastie action is of the utmost importance physiologically. 
The effect of accessory thromboplastin on the production of thrombln was found 
to be more conspicuous when  the kinase was diluted. In fact, it was often difficult 
to  detect dilute kinase without  adding accessory thromboplastin. There are many 
conceivable explanations,  some  of  which  have  been  discussed  elsewhere  (6).  One j.  H.  mI,STOl,  m  85 
possibility  which must be admitted here is that various subfractions  of the plasma 
globulins  might contain anticoagulant material which tends to obscure  the kinase. 
Howell repeatedly portrayed the function of his thromboplastin as an opposition  to 
some anticoagulant (2, 3). 
It is unnecessary to speculate further on the surprises this topic has in store. 
The chief present  purpose  is  to  group  these  accessory thromboplastins  to- 
gether on a  functional basis and to set them aside,  so that  they no longer 
obscure the basic mechanism. With regard to the basic mechanism,  the hy- 
pothesis fits the new facts. Many reports from other laboratories can be brought 
into  harmony with  this  hypothesis  if it  is  clearly appreciated  that:  First, 
kinase and accessory thromboplastin are different factors, often mistaken one 
for the  other,  and  often coexisting in plasma  globulin  derivatives;  second, 
kinase is a frequent and hitherto unrecognized contaminant of highly purified 
thrombin preparations. 
SUMMARy 
1.  Crude globulin from more than 1,000 liters of citrated bovine plasma has 
been used in developing a procedure for moderately large scale separation of 
clotting factors. Fraction A, prothrombin, kinase, and thrombin fractions were 
prepared.  Fraction  A  contained both kinase  and  accessory thromboplastin, 
the latter predominating when fraction A  was diluted. 
2.  When prothrombin was activated by kinase, the rate of thrombin produc- 
tion was enhanced by the  addition of platelets, or brain lipid, or dilute frac- 
tion A. These accessory thromboplastins caused this acceleration only when 
calcium chloride was added. Even with calcium, they were not effective unless 
kinase was present. 
3.  In contrast, the action of kinase was not entirely dependent on either 
ionic calcium or accessory thromboplastin. The concentrated kinase fraction 
activated prothrombin in the presence of excess oxalate. Although kinase often 
contaminates highly purified thrombins, it is probably distinct from thrombin. 
The ratio of kinase to thrombill was 100 times as great in the kinase  fraction 
as in the thrombin fraction. 
4.  The kinase fraction, diluted 45,000-fold, to protein-nitrogen  concentra- 
tions as low as 0.02 microgram per ml., accelerated the conversion of  crude 
prokinase in three-stage tests. 
5.  The findings are consistent with the following concept of the basic enzy- 
matic mechanism: 
Kinase 
I. Prokinase  ~ Kinase 
Kinase  2. Prothrombin  ---->  Thrombin 
Thrombin 
3. Fibrinogen  ~ Fibrin 86  FRACTIONATION OF BLOOD-CLOTTING SYSTE~ 
It is now added that calcium and accessory thromboplastin exert their effects 
by impinging on the basic mechanism, in a  chemically secondary or indirect 
manner. 
The huge amount of routine work was ably performed  by Anita GambardeUa Er- 
rico, David Aronson, and Austin Virchow Errico. 
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